Phase I and pharmacokinetic study of the oral farnesyltransferase inhibitor lonafarnib administered twice daily to pediatric patients with advanced central nervous system tumors using a modified continuous reassessment method: a Pediatric Brain Tumo (Q48102977)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I and pharmacokinetic study of the oral farnesyltransferase inhibitor lonafarnib administered twice daily to pediatric patients with advanced central nervous system tumors using a modified continuous reassessment method: a Pediatric Brain Tumo |
scientific article |
Statements
1 reference
Phase I and pharmacokinetic study of the oral farnesyltransferase inhibitor lonafarnib administered twice daily to pediatric patients with advanced central nervous system tumors using a modified continuous reassessment method: a Pediatric Brain Tumo (English)
1 reference
1 reference
1 reference
Susan M Blaney
1 reference
Roger J Packer
1 reference
Arzu Onar
1 reference
Peter Phillips
1 reference
Ian F Pollack
1 reference
J Russell Geyer
1 reference
Sri Gururangan
1 reference
Anu Banerjee
1 reference
Stewart Goldman
1 reference
Christopher D Turner
1 reference
Jean B Belasco
1 reference
Yali Zhu
1 reference
Emily Frank
1 reference
Paul Kirschmeier
1 reference
Paul Statkevich
1 reference
Antoine Yver
1 reference
James M Boyett
1 reference
Larry E Kun
1 reference
1 July 2007
1 reference
1 reference
25
1 reference
3137-3143
1 reference
21
1 reference
Identifiers
1 reference
1 reference